Cancer Diagnostics Market
According to Intent Market Research, the Cancer Diagnostics Market is expected to grow from USD 223.9 billion in 2023 at a CAGR of 10.1% to touch USD 439.6 billion by 2030. The Cancer Diagnostics Market is dominated by key players such as Roche Diagnostics, Abbott Laboratories, Thermo Fisher Scientific, Illumina, Siemens Healthineers, GE Healthcare, Bio-Rad Laboratories, Qiagen, Philips Healthcare, Guardant Health, Exact Sciences Corporation, Foundation Medicine, Beckman Coulter, LabCorp, Neogenomics.